Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - SAB Biotherapeutics, Inc. | StockGist | StockGist

Companies
SABS
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings SABSSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

SAB Biotherapeutics, Inc.

Filed Jan 22, 2026

Accepted Jan 21, 2026, 7:00 PM ET

CIK 0001833214

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

3,471,861

Reporting Person

SAB Biotherapeutics, Inc.

Person Type

IA

CUSIP: 78397T202

Amendment History

5 filings

SCHEDULE 13G
Original
Viewing
Jan 22, 20260001193125-26-019535
SCHEDULE 13G/A
Amendment 1
Feb 17, 20260001493215-26-000048
SCHEDULE 13G/A
Amendment 2
Feb 17, 20260001493215-26-000048
SCHEDULE 13G/A
Amendment 3
Feb 17, 20260000921895-26-000472
SCHEDULE 13G/A
Amendment 4
Latest
Feb 17, 20260000921895-26-000472

Key Facts

Shares Owned

3,471,861

Recent Filings

SAB Biotherapeutics, Inc.1 weeks ago

SAB Biotherapeutics, Inc.3 weeks ago

SAB Biotherapeutics, Inc.3 weeks ago

SAB Biotherapeutics, Inc.3 weeks ago

SAB Biotherapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice